Yung-Kuang Chen, MD
Family Medicine · Cupertino
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Chen’s office at (408) 996-3376 to ask if they take your plan before you enroll.
California Medical Board record
Licence A74211 · Current
Licensed to practise in California · since 2001 · expires 2027-04-30 · Temple University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$338
Pharmacies billed $338 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 44% of their Part D prescriptions (11 of 25) in 2024. Too few prescriptions to compare fairly with other clinicians.
24 generic and fewer than 11 brand-name prescriptions · $338 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Tramadol | 11 | $31 | $3 |
Year by year
| 2024 | 25 | None | 44% (11) | None | $338 |
| 2023 | 18 | None | None | None | $354 |
| 2022 | 27 | None | 52% (14) | None | $682 |
| 2021 | 27 | None | 48% (13) | 0% | $453 |
| 2020 | 27 | None | 44% (12) | 0% | $194 |
| 2019 | 23 | None | 52% (12) | 0% | $989 |
| 2018 | 15 | None | 73% (11) | None | $418 |
| 2017 | 11 | None | None | 0% | $223 |
| 2015 | 24 | None | 0% (0) | None | $768 |
| 2013 | 11 | None | None | None | $412 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2022: 1 drug
| Tramadol | 14 | $51 | $4 |
2021: 1 drug
| Tramadol | 13 | $69 | $5 |
2020: 2 drugs
| Gabapentin | 11 | $93 | $8 |
| Tramadol | 12 | $36 | $3 |
2019: 1 drug
| Tramadol | 12 | $249 | $21 |
2018: 1 drug
| Tramadol | 11 | $259 | $24 |
Money from drug and device companies
$53 in 2025
| 2025 | 1 | 1 | None | $53 |
| 2024 | 1 | 8 | None | $212 |
| 2023 | 1 | 2 | None | $241 |
| 2021 | 2 | 3 | None | $84 |
| 2020 | 1 | 1 | None | $34 |
| 2019 | 2 | 5 | None | $214 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Revance Therapeutics | Daxxify | $53 | 1 payment
|
See the published payment
| Revance Therapeutics | Meals · 2025-05-01 | Daxxify | $53 |
See earlier years (2024, 2023, 2021, 2020, 2019)
2024: $212
| Abbvie | Botox | $212 | 8 payments
|
2023: $241
| AbbVie | Botox | $241 | 2 payments
|
2021: $84
| Merz North America | None | $61 | 2 payments
|
| Allergan | Botox | $23 | 1 payment
|
2020: $34
| Apyx Medical | None | $34 | 1 payment
|
2019: $214
| Allergan | None | $124 | 1 payment
|
| Apyx Medical | None | $91 | 4 payments
|
Professional record
- NPI
- 1619009404
- Licence
- CA A74211California A74211: Current · expires 2027-04-30
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 10050 Bubb Rd, Suite #1, Cupertino, CA, 95014
- NPI first listed
- 2007-03-09
- NPI last updated
- 2015-12-10
This is when the NPI record was last certified, not a medical board exam.